Cargando…
Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis
Atherosclerosis is the main pathological basis of ischemic cardiovascular and cerebrovascular diseases and has attracted more attention in recent years. Multiple studies have demonstrated that the signal transducer and activator of transcription 3 (STAT3) plays essential roles in the process of athe...
Autores principales: | Chen, Qi, Lv, Jianjun, Yang, Wenwen, Xu, Baoping, Wang, Zheng, Yu, Zihao, Wu, Jiawei, Yang, Yang, Han, Yuehu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771242/ https://www.ncbi.nlm.nih.gov/pubmed/31588227 http://dx.doi.org/10.7150/thno.35528 |
Ejemplares similares
-
Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit
por: Yang, Xilan, et al.
Publicado: (2020) -
Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease
por: Szelag, Malgorzata, et al.
Publicado: (2016) -
Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
por: Li, Xue, et al.
Publicado: (2022) -
Isoliquiritigenin Inhibits Atherosclerosis by Blocking TRPC5 Channel Expression
por: Qi, Jie, et al.
Publicado: (2020) -
New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis
por: Luan, Yi, et al.
Publicado: (2022)